Literature DB >> 22674293

The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project.

Rebecca J Cleveland1, Kari E North, June Stevens, Susan L Teitelbaum, Alfred I Neugut, Marilie D Gammon.   

Abstract

PURPOSE: Diabetes has been associated with increased risk of breast cancer in a number of epidemiologic studies, but its effects on survival among women diagnosed with breast cancer have been examined less frequently. Importantly, prior investigations have rarely considered the influence of factors associated with diabetes such as obesity, age at diabetes diagnosis, duration of diabetes, or diabetes treatments.
METHODS: We evaluated the effect of self-reported diabetes on breast cancer incidence and mortality in the Long Island Breast Cancer Study Project, which includes 1,447 breast cancer cases and 1,453 controls. Follow-up data for all-cause (n = 395) and 5-year breast cancer-specific mortality (n = 104) through December 2005 were determined for case women from the National Death Index. Adjusted logistic regression and Cox proportional hazards models were used to estimate odds ratios (OR) and hazards ratios (HR), respectively.
RESULTS: Postmenopausal women with diabetes were at increased risk of developing breast cancer [OR = 1.35; 95 % confidence interval (CI) = 0.99-1.85], as were those who were not of white race regardless of menopausal status [OR = 3.89; 95 % CI = 1.66-9.11]. Among case women, diabetes was associated with a modestly increased risk of death from all causes [HR = 1.65; 95 % CI = 1.18-2.29], an association that was stronger in women who were obese at breast cancer diagnosis [HR = 2.49; 94 % CI = 1.58-3.93]. In analyses restricted to diabetics, there was no statistically significant effect of duration of diabetes or type of treatment on breast cancer incidence or mortality.
CONCLUSIONS: Our findings suggest that diabetes may increase incidence of breast cancer in older women and non-whites, and mortality due to all causes.

Entities:  

Mesh:

Year:  2012        PMID: 22674293      PMCID: PMC3383781          DOI: 10.1007/s10552-012-9989-7

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  50 in total

Review 1.  Obesity as a risk factor for development and poor prognosis of breast cancer.

Authors:  A R Carmichael
Journal:  BJOG       Date:  2006-08-31       Impact factor: 6.531

2.  Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.

Authors:  R Yancik; M N Wesley; L A Ries; R J Havlik; B K Edwards; J W Yates
Journal:  JAMA       Date:  2001-02-21       Impact factor: 56.272

3.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

Authors:  T Key; P Appleby; I Barnes; G Reeves
Journal:  J Natl Cancer Inst       Date:  2002-04-17       Impact factor: 13.506

4.  Dual effects of weight and weight gain on breast cancer risk.

Authors:  Z Huang; S E Hankinson; G A Colditz; M J Stampfer; D J Hunter; J E Manson; C H Hennekens; B Rosner; F E Speizer; W C Willett
Journal:  JAMA       Date:  1997-11-05       Impact factor: 56.272

5.  Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

Authors:  Pamela J Goodwin; Marguerite Ennis; Kathleen I Pritchard; Maureen E Trudeau; Jarley Koo; Yolanda Madarnas; Warren Hartwick; Barry Hoffman; Nicky Hood
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

Review 6.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

7.  Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults.

Authors:  Steven S Coughlin; Eugenia E Calle; Lauren R Teras; Jennifer Petrelli; Michael J Thun
Journal:  Am J Epidemiol       Date:  2004-06-15       Impact factor: 4.897

8.  Sulphonylureas and cancer: a case-control study.

Authors:  Matteo Monami; Caterina Lamanna; Daniela Balzi; Niccolò Marchionni; Edoardo Mannucci
Journal:  Acta Diabetol       Date:  2008-12-10       Impact factor: 4.280

9.  Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.

Authors:  Anthony J G Hanley; Andreas Festa; Ralph B D'Agostino; Lynne E Wagenknecht; Peter J Savage; Russell P Tracy; Mohammed F Saad; Steven M Haffner
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

Review 10.  Medication taking and diabetes: a systematic review of the literature.

Authors:  Peggy Soule Odegard; Kam Capoccia
Journal:  Diabetes Educ       Date:  2007 Nov-Dec       Impact factor: 2.140

View more
  28 in total

1.  Diabetes, diabetes treatment and breast cancer prognosis.

Authors:  Juhua Luo; Beth Virnig; Michael Hendryx; Sijin Wen; Rowan Chelebowski; Chu Chen; Tomas Rohan; Lesley Tinker; Jean Wactawski-Wende; Lawrence Lessin; Karen Margolis
Journal:  Breast Cancer Res Treat       Date:  2014-09-27       Impact factor: 4.872

Review 2.  BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.

Authors:  Dequina A Nicholas; Guillaume Andrieu; Katherine J Strissel; Barbara S Nikolajczyk; Gerald V Denis
Journal:  Cell Mol Life Sci       Date:  2016-08-04       Impact factor: 9.261

3.  Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population-based study.

Authors:  Tengteng Wang; Lauren E McCullough; Alexandra J White; Patrick T Bradshaw; Xinran Xu; Yoon Hee Cho; Mary Beth Terry; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella; Jia Chen; Marilie D Gammon
Journal:  Cancer       Date:  2019-08-12       Impact factor: 6.860

4.  Diabetes and Overall Survival among Breast Cancer Patients in the U.S. Military Health System.

Authors:  Stephanie Shao; Abegail A Gill; Shelia H Zahm; Ismail Jatoi; Craig D Shriver; Katherine A McGlynn; Kangmin Zhu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11-02       Impact factor: 4.254

5.  Genetic polymorphisms of diabetes-related genes, their interaction with diabetes status, and breast cancer incidence and mortality: The Long Island Breast Cancer Study Project.

Authors:  Humberto Parada; Rebecca J Cleveland; Kari E North; June Stevens; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella; Maria E Martinez; Marilie D Gammon
Journal:  Mol Carcinog       Date:  2018-12-11       Impact factor: 4.784

6.  Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population-based case-control study.

Authors:  Jayeon Kim; Jennifer E Mersereau; Nikhil Khankari; Patrick T Bradshaw; Lauren E McCullough; Rebecca Cleveland; Sumitra Shantakumar; Susan L Teitelbuam; Alfred I Neugut; Ruby T Senie; Marilie D Gammon
Journal:  Cancer Causes Control       Date:  2016-01-21       Impact factor: 2.506

7.  Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis.

Authors:  Hong Xu; Kai Chen; Xiaoyan Jia; Yali Tian; Yun Dai; Dapeng Li; Jing Xie; Min Tao; Yixiang Mao
Journal:  Oncologist       Date:  2015-10-07

Review 8.  The prognostic outcome of 'type 2 diabetes mellitus and breast cancer' association pivots on hypoxia-hyperglycemia axis.

Authors:  Ilhaam Ayaz Durrani; Attya Bhatti; Peter John
Journal:  Cancer Cell Int       Date:  2021-07-05       Impact factor: 5.722

9.  Risks of Breast and Endometrial Cancer in Women with Diabetes: A Population-Based Cohort Study.

Authors:  Hua-Fen Chen; Ming-Der Liu; Peter Chen; Li-Huan Chen; Ya-Hui Chang; Pei-Chun Wen; Chung-Yi Li
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

10.  Type 2 diabetes mellitus, oral diabetic medications, insulin therapy, and overall breast cancer risk.

Authors:  Hala Ahmadieh; Sami T Azar
Journal:  ISRN Endocrinol       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.